publication venue for
- Donor composition and fiber promote strain engraftment in a randomized controlled trial of fecal microbiota transplant for ulcerative colitis. 2025
- A randomized phase 2 study of HLX22 plus trastuzumab biosimilar HLX02 and XELOX as first-line therapy for HER2-positive advanced gastric cancer.. 5. 2024
- Adaptive conductive electrotherapeutic scaffolds for enhanced peripheral nerve regeneration and stimulation.. 4. 2023
- Forecasting cancer: from precision to predictive medicine.. 2. 2021
- Targeted Phage Display-based Pulmonary Vaccination in Mice and Non-human Primates.. 2. 2020
- Lightning does strike twice: leveraging phased variants to enhance minimal residual disease detection. 2021